
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Suzetrigine as a Novel Non-opioid Analgesic Drug in Pain Management: A Review of Clinical Evidence and Therapeutic Perspectives - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4A1718AF1D5B305A1710058E4A72D.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="cureus">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372998/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Cureus">
<meta name="citation_title" content="Suzetrigine as a Novel Non-opioid Analgesic Drug in Pain Management: A Review of Clinical Evidence and Therapeutic Perspectives">
<meta name="citation_author" content="Maciej Mach">
<meta name="citation_author_institution" content="Department of General, Vascular, Endocrine, and Transplant Surgery, Medical University of Warsaw, Warsaw, POL">
<meta name="citation_author" content="Aleksandra Giba">
<meta name="citation_author_institution" content="Department of General, Vascular, Endocrine, and Transplant Surgery, Medical University of Warsaw, Warsaw, POL">
<meta name="citation_author" content="Milosz Miedziaszczyk">
<meta name="citation_author_institution" content="Department of Clinical Pharmacy and Biopharmacy, Poznań University of Medical Sciences, Poznań, POL">
<meta name="citation_author" content="Adrian Bryla">
<meta name="citation_author_institution" content="Department of Clinical Pharmacology, Jagiellonian University, Kraków, POL">
<meta name="citation_author_institution" content="Department of Clinical Pharmacy, Ludwik Rydygier Specialist Hospital, Kraków, POL">
<meta name="citation_author" content="Danuta Szkutnik-Fiedler">
<meta name="citation_author_institution" content="Department of Clinical Pharmacy and Biopharmacy, Poznań University of Medical Sciences, Poznań, POL">
<meta name="citation_publication_date" content="2025 Aug 22">
<meta name="citation_volume" content="17">
<meta name="citation_issue" content="8">
<meta name="citation_firstpage" content="e90755">
<meta name="citation_doi" content="10.7759/cureus.90755">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372998/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372998/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372998/pdf/cureus-0017-00000090755.pdf">
<meta name="description" content="The NaV1.8 sodium channel plays a key role in the transmission of pain signals in peripheral sensory neurons. Suzetrigine is a selective NaV1.8 inhibitor developed as a non-opioid analgesic. Its action is limited to sensory neurons, reducing the ...">
<meta name="og:title" content="Suzetrigine as a Novel Non-opioid Analgesic Drug in Pain Management: A Review of Clinical Evidence and Therapeutic Perspectives">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="The NaV1.8 sodium channel plays a key role in the transmission of pain signals in peripheral sensory neurons. Suzetrigine is a selective NaV1.8 inhibitor developed as a non-opioid analgesic. Its action is limited to sensory neurons, reducing the ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372998/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12372998">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.7759/cureus.90755"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/cureus-0017-00000090755.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372998%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12372998/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12372998/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372998/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-cureus.png" alt="Cureus logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Cureus" title="Link to Cureus" shape="default" href="http://www.cureus.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Cureus</button></div>. 2025 Aug 22;17(8):e90755. doi: <a href="https://doi.org/10.7759/cureus.90755" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.7759/cureus.90755</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Cureus%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cureus%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Cureus%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Cureus%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Suzetrigine as a Novel Non-opioid Analgesic Drug in Pain Management: A Review of Clinical Evidence and Therapeutic Perspectives</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mach%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Maciej Mach</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Maciej Mach</span></h3>
<div class="p">
<sup>1</sup>
Department of General, Vascular, Endocrine, and Transplant Surgery, Medical University of Warsaw, Warsaw, POL </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mach%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Maciej Mach</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Giba%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Aleksandra Giba</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Aleksandra Giba</span></h3>
<div class="p">
<sup>1</sup>
Department of General, Vascular, Endocrine, and Transplant Surgery, Medical University of Warsaw, Warsaw, POL </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Giba%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Aleksandra Giba</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Miedziaszczyk%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Milosz Miedziaszczyk</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Milosz Miedziaszczyk</span></h3>
<div class="p">
<sup>2</sup>
Department of Clinical Pharmacy and Biopharmacy, Poznań University of Medical Sciences, Poznań, POL </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Miedziaszczyk%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Milosz Miedziaszczyk</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bryla%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Adrian Bryla</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Adrian Bryla</span></h3>
<div class="p">
<sup>3</sup>
Department of Clinical Pharmacology, Jagiellonian University, Kraków, POL </div>
<div class="p">
<sup>4</sup>
Department of Clinical Pharmacy, Ludwik Rydygier Specialist Hospital, Kraków, POL </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bryla%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Adrian Bryla</span></a>
</div>
</div>
<sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Szkutnik-Fiedler%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Danuta Szkutnik-Fiedler</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Danuta Szkutnik-Fiedler</span></h3>
<div class="p">
<sup>2</sup>
Department of Clinical Pharmacy and Biopharmacy, Poznań University of Medical Sciences, Poznań, POL </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Szkutnik-Fiedler%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Danuta Szkutnik-Fiedler</span></a>
</div>
</div>
<sup>2</sup>
</div>
<div class="cg p">Editors: <span class="name western">Alexander Muacevic</span>, <span class="name western">John R Adler</span>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff-1">
<sup>1</sup>
Department of General, Vascular, Endocrine, and Transplant Surgery, Medical University of Warsaw, Warsaw, POL </div>
<div id="aff-2">
<sup>2</sup>
Department of Clinical Pharmacy and Biopharmacy, Poznań University of Medical Sciences, Poznań, POL </div>
<div id="aff-3">
<sup>3</sup>
Department of Clinical Pharmacology, Jagiellonian University, Kraków, POL </div>
<div id="aff-4">
<sup>4</sup>
Department of Clinical Pharmacy, Ludwik Rydygier Specialist Hospital, Kraków, POL </div>
<div class="author-notes p">
<div class="fn" id="cor1">
<sup>✉</sup><p class="display-inline">
Maciej Mach <span>maciejmach1@wp.pl</span>
</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Accepted 2025 Aug 22; Collection date 2025 Aug.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © 2025, Mach et al.</div>
<p>This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12372998</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>The NaV1.8 sodium channel plays a key role in the transmission of pain signals in peripheral sensory neurons. Suzetrigine is a selective NaV1.8 inhibitor developed as a non-opioid analgesic. Its action is limited to sensory neurons, reducing the risk of adverse effects associated with non-selective sodium channel blockers. Phase II and III clinical trials have demonstrated the high efficacy of suzetrigine in managing postoperative pain, along with good tolerability. Adverse events, such as dizziness or drowsiness, were rare and generally mild to moderate in intensity. The drug did not cause respiratory depression or addiction, which distinguishes it from opioids. Ongoing pharmacokinetic studies and long-term observations aim to further define the drug’s safety profile and its potential use in patients with comorbid conditions. Suzetrigine may offer an effective and safe alternative to opioids in pain treatment.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> neuropathic pain, nociceptive pain, non-opioid drug, pain management, suzetrigine</p></section></section><section id="sec1"><h2 class="pmc_sec_title">Introduction and background</h2>
<p>Pain is a subjective, unpleasant sensory and emotional experience associated with actual or potential tissue damage [<a href="#REF1" class="usa-link" aria-describedby="REF1">1</a>]. The process of pain signal transmission can be divided into four main stages: transduction, transmission, modulation, and perception. During transduction, nociceptors detect harmful stimuli and convert them into nerve impulses. These signals are then transmitted to the spinal cord via Aδ and C fibers, and from there, they ascend through the spinothalamic tract to the thalamus [<a href="#REF2" class="usa-link" aria-describedby="REF2">2</a>].</p>
<p>At the transmission stage, pain signals may undergo modification through modulatory processes that influence individual pain perception [<a href="#REF3" class="usa-link" aria-describedby="REF3">3</a>]. Modulation occurs at various levels of the nervous system and includes mechanisms such as the activation of opioid receptors by endogenous and exogenous opioids, autonomic responses, and regulation of N-methyl-D-aspartate (NMDA) receptor and gamma-aminobutyric acid (GABA) signaling [<a href="#REF3" class="usa-link" aria-describedby="REF3">3</a>].</p>
<p>Once the signal reaches the brain, perception occurs - a process involving multiple cortical and subcortical structures that not only interpret the pain stimuli but also dynamically modulate them [<a href="#REF2" class="usa-link" aria-describedby="REF2">2</a>]. Analgesic drugs act at various stages of the pain pathway to reduce its intensity.</p>
<p>Despite being a cornerstone of moderate to severe pain management, opioids present significant limitations, including the risk of tolerance, dependence, respiratory depression, and opioid-induced hyperalgesia [<a href="#REF4" class="usa-link" aria-describedby="REF4">4</a>]. The ongoing opioid crisis has further highlighted the urgent need for alternative analgesics that provide effective pain relief without these adverse outcomes.</p>
<p>Depending on the type of pain, non-opioid treatments may include first-step analgesics (according to the analgesic ladder), as well as non-selective sodium channel blockers (e.g., lidocaine, mexiletine, and carbamazepine), gabapentinoids, and antidepressants [<a href="#REF5" class="usa-link" aria-describedby="REF5">5</a>]. The World Health Organization (WHO) analgesic ladder is a stepwise approach to pain management, illustrated in Figure <a href="#FIG1" class="usa-link">1</a> with an example placement of suzetrigine.</p>
<figure class="fig xbox font-sm" id="FIG1"><h3 class="obj_head">Figure 1. The WHO analgesic ladder with the proposed positioning of suzetrigine.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372998_cureus-0017-00000090755-i01.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c87/12372998/dab0bdbd082f/cureus-0017-00000090755-i01.jpg" loading="lazy" height="467" width="750" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/FIG1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Image credit: Maciej Mach</p></figcaption></figure><p>Non-steroidal anti-inflammatory drugs (NSAIDs) and paracetamol relieve pain by inhibiting enzymes responsible for inflammatory processes - cyclooxygenase (COX) and peroxidase (POX). Local anesthetics block the conduction of pain impulses by inhibiting sodium channels, whereas gabapentinoids affect glutamate uptake and block calcium channels. NMDA receptor antagonists, such as ketamine, as well as opioids, contribute to the modulation of pain pathways, thereby reducing the sensation of pain [<a href="#REF3" class="usa-link" aria-describedby="REF3">3</a>].</p>
<p>In pain management, it is essential to maintain a balance between providing adequate analgesia and minimizing the risk of adverse effects. Recently, researchers have discovered that NaV1.8 - a specific sodium channel in the body - plays a key role in how pain is perceived. Drugs that block NaV1.8, such as suzetrigine, may offer effective pain relief. Suzetrigine is an oral, selective NaV1.8 inhibitor that has demonstrated more than 31,000-fold greater selectivity for NaV1.8 compared to other NaV subtypes [<a href="#REF6" class="usa-link" aria-describedby="REF6">6</a>].</p>
<p>The goal of this article is to evaluate the therapeutic potential and safety profile of suzetrigine, employing a systematic review of preclinical and clinical studies as the primary method to synthesize current evidence.</p></section><section id="sec2"><h2 class="pmc_sec_title">Review</h2>
<p>Mechanism of action</p>
<p>The discovery of the role that voltage-gated sodium channels (NaV) play in pain transmission has initiated research into the potential analgesic applications of NaV modulators. Among the nine known NaV subtypes (NaV1.1 to NaV1.9), NaV1.7, NaV1.8, and NaV1.9 are preferentially expressed in nociceptive neurons within the peripheral nervous system [<a href="#REF7" class="usa-link" aria-describedby="REF7">7</a>].</p>
<p>Through this mechanism, the drug demonstrates potential efficacy in treating both nociceptive and neuropathic pain. Preclinical and early clinical studies have shown effective inhibition of pain signal conduction by sensory fibers, without affecting motor functions or other sodium channels not involved in pain perception [<a href="#REF8" class="usa-link" aria-describedby="REF8">8</a>].</p>
<p>Initial investigations into NaV1.7 inhibitors did not yield the expected clinical outcomes due to insufficient spinal inhibition, short duration of action, toxicity, and limited bioavailability. Development of NaV1.9 inhibitors faced challenges related to the expression of functional channels in vitro, redirecting focus to NaV1.8.</p>
<p>The voltage-gated sodium channel NaV1.8 plays a critical role in nociceptive signal transmission and represents an attractive therapeutic target for pain management (Figure <a href="#FIG2" class="usa-link">2</a>). Its selective expression in peripheral nociceptive neurons of the dorsal root ganglia, and its involvement in physiological sensory responses, underscore its importance in pain conduction mechanisms.</p>
<figure class="fig xbox font-sm" id="FIG2"><h3 class="obj_head">Figure 2. Suzetrigine's mechanism of action.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372998_cureus-0017-00000090755-i02.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c87/12372998/f7c9e85bc6da/cureus-0017-00000090755-i02.jpg" loading="lazy" height="436" width="750" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/FIG2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Created under a Creative Commons license in BioRender (<a href="https://BioRender.com/6qh0nzb" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://BioRender.com/6qh0nzb</a>)</p>
<p>Image credit: Maciej Mach</p></figcaption></figure><p>The role of NaV1.8 has been confirmed in studies of SCN10A gene mutations, animal models, and pharmacological analyses of agents modulating its activity. NaV1.8 plays a key role in the generation and propagation of action potentials in pain pathways, particularly under conditions of inflammation or nerve injury [<a href="#REF9" class="usa-link" aria-describedby="REF9">9</a>].</p>
<p>By selectively blocking NaV1.8, suzetrigine reduces neuronal hyperexcitability without affecting central nervous system function, thereby providing analgesia with a lower risk of addiction or sedation compared to opioids. Its peripherally restricted action minimizes central side effects, making it a promising non-opioid treatment for moderate to severe acute pain [<a href="#REF5" class="usa-link" aria-describedby="REF5">5</a>,<a href="#REF9" class="usa-link" aria-describedby="REF9">9</a>]. This mechanism is especially relevant, as it targets pathological pain signaling at its origin - within peripheral sensory neurons - rather than centrally modulating pain perception.</p>
<p>Furthermore, suzetrigine is a highly potent inhibitor of the NaV1.8 channel, demonstrating exceptional selectivity, with a half-maximal inhibitory concentration (IC<sub>50</sub>) of 0.27 nanomoles (nM) and over 30,000-fold preference compared to other sodium channel subtypes. At increased concentrations (IC<sub>50</sub> of 200 nM), it also shows efficacy in blocking sodium channels in an in vivo animal model [<a href="#REF10" class="usa-link" aria-describedby="REF10">10</a>].</p>
<p>Studies have demonstrated that orally administered suzetrigine interacts with NaV1.8 by stabilizing the channel in a closed state. Confirmation of this mechanism requires intense and prolonged depolarization of cells to reveal the effect of relief from inhibition, described as reverse use-dependence [<a href="#REF11" class="usa-link" aria-describedby="REF11">11</a>].</p>
<p>Although, theoretically, this could reduce efficacy under conditions of repetitive stimulation, results indicate that suzetrigine effectively maintains inhibition even during repeated depolarizations mimicking nociceptive signals in sensory neurons. Thus, it can be classified as a tonic NaV1.8 inhibitor, as its activity is not dependent on channel opening and persists across a wide range of voltages and impulse frequencies characteristic of painful states [<a href="#REF8" class="usa-link" aria-describedby="REF8">8</a>].</p>
<p>However, modulation of NaV channels must be approached with caution due to their expression in cardiomyocytes and potential cardiovascular effects. NaV1.8 mutations have been linked to Brugada syndrome, and their overexpression may contribute to heart failure and cardiac hypertrophy.</p>
<p>Lidocaine, a non-selective NaV inhibitor used in pain treatment, exhibits analgesic effects at low doses, but higher doses increase the risk of cardiac complications due to its impact on other NaV subtypes, such as NaV1.5, which is essential for cardiac function [<a href="#REF6" class="usa-link" aria-describedby="REF6">6</a>].</p>
<p>Pharmacokinetics</p>
<p>Suzetrigine is well absorbed following oral administration and exhibits a long half-life of approximately 30-60 hours, enabling once- or twice-daily dosing while maintaining plasma concentrations in the low-nanomolar range required for near-complete inhibition of NaV1.8 (IC<sub>50</sub> in humans ≈ 0.68 nM) in clinical studies [<a href="#REF8" class="usa-link" aria-describedby="REF8">8</a>,<a href="#REF12" class="usa-link" aria-describedby="REF12">12</a>]. It is primarily metabolized in the liver via glucuronidation, with minimal renal excretion; thus, caution is recommended in patients with hepatic impairment, whereas dose adjustment is generally unnecessary in those with renal dysfunction [<a href="#REF8" class="usa-link" aria-describedby="REF8">8</a>,<a href="#REF12" class="usa-link" aria-describedby="REF12">12</a>].</p>
<p>Preclinical studies have shown that its pharmacokinetics may vary significantly by sex, with female rats exhibiting markedly higher systemic exposure, area under the curve (AUC<sub>0-t</sub>) up to 50-fold greater, and oral bioavailability (96% vs. 11% in males), due to slower metabolism via cytochrome (CYP) CYP3A2- and CYP2C11-mediated demethylation [<a href="#REF13" class="usa-link" aria-describedby="REF13">13</a>].</p>
<p>Animal pharmacokinetic profiling in monkeys confirmed good oral bioavailability and stable plasma levels, with validated liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods supporting accurate quantification in preclinical trials [<a href="#REF14" class="usa-link" aria-describedby="REF14">14</a>].</p>
<p>Distribution studies show that suzetrigine selectively acts on peripheral sensory neurons, with no detectable SCN10A (NaV1.8 gene) expression in the central nervous system [<a href="#REF15" class="usa-link" aria-describedby="REF15">15</a>]. This peripherally restricted activity reduces the likelihood of central nervous system side effects.</p>
<p>Across species, potency varies, with the highest sensitivity observed in humans and non-human primates. Its low potential for drug-drug interactions, particularly with other analgesic drugs, makes it an attractive candidate for combination therapy [<a href="#REF4" class="usa-link" aria-describedby="REF4">4</a>]. However, the prolonged half-life may delay steady-state attainment and extend the duration of adverse effects, necessitating careful dose titration [<a href="#REF8" class="usa-link" aria-describedby="REF8">8</a>,<a href="#REF16" class="usa-link" aria-describedby="REF16">16</a>].</p>
<p>Indications</p>
<p>Effective management of acute pain requires a balance between providing adequate analgesia and minimizing the risk of adverse effects [<a href="#REF17" class="usa-link" aria-describedby="REF17">17</a>]. Poorly controlled pain can lead to complications such as delayed recovery, prolonged hospital stays, and reduced quality of life [<a href="#REF18" class="usa-link" aria-describedby="REF18">18</a>]. Furthermore, inadequate treatment of acute pain increases the risk of its transition to a chronic form, which carries significant socio-economic costs [<a href="#REF19" class="usa-link" aria-describedby="REF19">19</a>,<a href="#REF20" class="usa-link" aria-describedby="REF20">20</a>].</p>
<p>Currently, the treatment of acute pain involves a multimodal strategy, incorporating different classes of medications, including NSAIDs, acetaminophen, local anesthetics, and NMDA receptor antagonists [<a href="#REF3" class="usa-link" aria-describedby="REF3">3</a>]. Despite the availability of the above-mentioned options, opioids remain a cornerstone in the treatment of moderate to severe pain. However, their use is associated with adverse effects such as sedation, respiratory depression, nausea, vomiting, constipation, and renal dysfunction [<a href="#REF21" class="usa-link" aria-describedby="REF21">21</a>].</p>
<p>Moreover, opioid pain treatment in the USA leads to approximately 85,000 cases of opioid use disorder (OUD) annually [<a href="#REF22" class="usa-link" aria-describedby="REF22">22</a>,<a href="#REF23" class="usa-link" aria-describedby="REF23">23</a>]. Managing pain in such individuals remains a clinical challenge due to the risk of relapse and the limited range of effective non-opioid alternatives [<a href="#REF22" class="usa-link" aria-describedby="REF22">22</a>,<a href="#REF23" class="usa-link" aria-describedby="REF23">23</a>].</p>
<p>In this context, suzetrigine has been investigated as a promising solution, as preclinical and early clinical studies suggest that it exerts analgesic effects through selective inhibition of peripheral sodium channels, without engaging opioid receptors [<a href="#REF5" class="usa-link" aria-describedby="REF5">5</a>,<a href="#REF9" class="usa-link" aria-describedby="REF9">9</a>]. This mechanism is hypothesized to lower the risk of abuse or physical dependence compared with opioids, which could make suzetrigine a potentially valuable option for patients with a history of substance use disorders [<a href="#REF24" class="usa-link" aria-describedby="REF24">24</a>]. Selective inhibition of the voltage-gated sodium channel NaV1.8 has emerged as a promising therapeutic approach, with NaV1.8 inhibitors showing potential to provide effective and well-tolerated analgesia in acute and chronic pain [<a href="#REF25" class="usa-link" aria-describedby="REF25">25</a>,<a href="#REF26" class="usa-link" aria-describedby="REF26">26</a>].</p>
<p>Suzetrigine has the potential to alleviate both acute postoperative pain and chronic neuropathic pain - including pain associated with neuralgia, diabetes, or peripheral nerve injury. Given its mechanism of action and safety profile, it may be suitable for patients with moderate to severe pain, particularly when other treatments are ineffective, poorly tolerated, or when opioid use is contraindicated or carries a risk of dependence [<a href="#REF24" class="usa-link" aria-describedby="REF24">24</a>,<a href="#REF27" class="usa-link" aria-describedby="REF27">27</a>-<a href="#REF29" class="usa-link" aria-describedby="REF29">29</a>].</p>
<p>Blocking NaV1.8 channels allows for selective pain suppression without a generalized depressive effect on the central nervous system, distinguishing suzetrigine from opioids and making it a novel alternative in pain management [<a href="#REF8" class="usa-link" aria-describedby="REF8">8</a>]. Nevertheless, further large-scale clinical studies are needed to confirm its efficacy and safety. Data on its use in multimodal analgesia, and in pregnant or breastfeeding patients, are also of particular importance [<a href="#REF6" class="usa-link" aria-describedby="REF6">6</a>].</p>
<p>Efficacy</p>
<p>NaV1.8 channels represent an attractive therapeutic target for pain management due to their predominant expression in primary sensory neurons and minimal presence in most other neuron types [<a href="#REF11" class="usa-link" aria-describedby="REF11">11</a>]. Suzetrigine has demonstrated high efficacy in pain reduction during clinical trials and has shown greater potency compared to another compound with a similar mechanism of action, VX-150. It exhibits a unique “reverse use-dependence,” meaning its inhibitory effect can be attenuated by repetitive depolarizations [<a href="#REF11" class="usa-link" aria-describedby="REF11">11</a>]. This process occurs with a time constant of approximately 40 milliseconds (ms), independent of drug concentration, whereas re-inhibition at negative voltages is proportional to concentration. This suggests that suzetrigine binds strongly to NaV1.8 channels in the resting state, but much less so to channels with fully activated voltage sensors, indicating a distinctive state-dependent inhibition [<a href="#REF11" class="usa-link" aria-describedby="REF11">11</a>].</p>
<p>Two pivotal randomized controlled trials (NAVIGATE-1 and NAVIGATE-2) assessed the efficacy of suzetrigine in adult patients experiencing moderate to severe acute pain following abdominoplasty and bunionectomy [<a href="#REF30" class="usa-link" aria-describedby="REF30">30</a>]. Patients receiving suzetrigine - a 100-milligram (mg) loading dose, followed by 50 mg every 12 hours - reported significantly greater pain relief compared to placebo, as measured by the sum of pain intensity differences over 48 hours (SPID48) outcome [<a href="#REF30" class="usa-link" aria-describedby="REF30">30</a>]. In the abdominoplasty trial, the least squares mean difference (LSMD) between suzetrigine and placebo was 48.4 (p &lt; 0.0001), while in the bunionectomy trial it was 29.3 (p = 0.0002) [<a href="#REF30" class="usa-link" aria-describedby="REF30">30</a>]. Suzetrigine also reduced pain more rapidly than placebo, with a clinically meaningful numeric pain rating scale (NPRS) decrease achieved in two to four hours versus eight hours with placebo [<a href="#REF30" class="usa-link" aria-describedby="REF30">30</a>]. Compared to low-dose opioids - hydrocodone/acetaminophen (HB5/APAP325) - suzetrigine showed similar or slightly lower efficacy, depending on the procedure: it performed better in abdominoplasty but was inferior in bunionectomy [<a href="#REF30" class="usa-link" aria-describedby="REF30">30</a>]. A network meta-analysis further indicated that suzetrigine’s analgesic effect was comparable to that of NSAIDs and slightly lower than high-dose opioids [<a href="#REF30" class="usa-link" aria-describedby="REF30">30</a>]. Overall, suzetrigine was well tolerated, with fewer gastrointestinal side effects than opioids, and a discontinuation rate below 1% [<a href="#REF30" class="usa-link" aria-describedby="REF30">30</a>].</p>
<p>In a single-arm study assessing suzetrigine’s effectiveness in treating acute pain of both surgical and non-surgical origin, 83.2% of patients experiencing moderate to severe pain rated the treatment as good, very good, or excellent on the Patient Global Assessment (PGA) scale [<a href="#REF31" class="usa-link" aria-describedby="REF31">31</a>]. In this study, participants were allowed to take additional acetaminophen (650 mg) and ibuprofen (400 mg) every six hours, referred to as rescue medication, whenever extra pain relief was necessary. Notably, the high rate of positive assessments was consistent regardless of pain type - 82.0% among surgical patients and 91.2% among non-surgical patients - and suzetrigine’s efficacy was not significantly influenced by the use of rescue medications [<a href="#REF31" class="usa-link" aria-describedby="REF31">31</a>]. Only 1.6% of patients discontinued therapy due to lack of efficacy, further confirming the drug’s favorable tolerability profile [<a href="#REF31" class="usa-link" aria-describedby="REF31">31</a>].</p>
<p>Dosage</p>
<p>Phase II and III clinical trials evaluated the efficacy and safety of various dosing regimens for the treatment of acute postoperative pain [<a href="#REF5" class="usa-link" aria-describedby="REF5">5</a>,<a href="#REF6" class="usa-link" aria-describedby="REF6">6</a>,<a href="#REF32" class="usa-link" aria-describedby="REF32">32</a>]. Both phases employed the same regimen: a loading dose of 100 mg, followed by 50 mg every 12 hours for 48 hours post-surgery.</p>
<p>In two Phase II studies involving patients after abdominoplasty and hallux valgus correction surgery, a significant reduction in pain intensity (SPID) over 48 hours was observed only in the high-dose group compared to placebo [<a href="#REF5" class="usa-link" aria-describedby="REF5">5</a>]. Lower doses did not demonstrate significant superiority over either placebo or hydrocodone combined with acetaminophen. These findings were confirmed in two Phase III trials including over 2,000 patients - the high-dose regimen provided a rapid and sustained analgesic effect clearly superior to placebo, though comparable or slightly less potent than hydrocodone with acetaminophen [<a href="#REF32" class="usa-link" aria-describedby="REF32">32</a>]. The 100 mg loading dose, followed by 50 mg every 12 hours, is currently considered the most effective dosing regimen among those studied to date [<a href="#REF6" class="usa-link" aria-describedby="REF6">6</a>].</p>
<p>Adverse effects</p>
<p>Preclinical studies in rats and monkeys showed no significant adverse effects or potential for dependence [<a href="#REF8" class="usa-link" aria-describedby="REF8">8</a>]. No neurobehavioral, sedative, or stimulatory effects were observed. Suzetrigine did not induce physical dependence symptoms after abrupt discontinuation, even at doses many times higher than therapeutic levels. No adverse effects on the cardiovascular or respiratory systems - including blood pressure or electrocardiogram (ECG) changes - were reported, even with long-term use.</p>
<p>In two Phase II clinical trials involving patients with acute pain following abdominoplasty (n = 303) and hallux valgus surgery (n = 274), the drug demonstrated good tolerability and a favorable safety profile [<a href="#REF5" class="usa-link" aria-describedby="REF5">5</a>]. The most common adverse events (≥10%) were nausea, headache, constipation, dizziness, and vomiting. These symptoms were mild, resolved spontaneously or with symptomatic treatment, and did not lead to treatment discontinuation. Serious adverse events - such as pulmonary embolism (in the group receiving an average dose of suzetrigine), laryngeal stenosis (hydrocodone with acetaminophen group), and cellulitis with sepsis (placebo group) - occurred in isolated patients and were not related to the study drug. Treatment discontinuation rates were lower in suzetrigine groups compared to placebo and hydrocodone/acetaminophen groups.</p>
<p>A separate clinical safety study confirmed good drug tolerability. Most adverse events were mild or moderate, with the most frequent being headache, constipation, nausea, falls, and rash; only headache occurred in more than 5% of participants (7.0%) [<a href="#REF28" class="usa-link" aria-describedby="REF28">28</a>]. Serious adverse events were reported in only two patients (0.8%) - one with suicidal ideation and another who developed cellulitis. Both cases were deemed unrelated to suzetrigine therapy [<a href="#REF31" class="usa-link" aria-describedby="REF31">31</a>].</p>
<p>Some patients also experienced skin rash and mild cognitive symptoms, such as difficulty concentrating. These reactions appear dose-dependent and are generally mild to moderate in severity [<a href="#REF8" class="usa-link" aria-describedby="REF8">8</a>]. Despite initial optimism, concerns arose regarding potential neurotoxicity at higher doses and proarrhythmic risk observed in in vitro studies [<a href="#REF8" class="usa-link" aria-describedby="REF8">8</a>]. Additionally, like other sodium channel blockers, suzetrigine may carry a risk of hypersensitivity reactions, although this appears less frequent than with lamotrigine. Due to hepatic metabolism, the drug should be used cautiously - or avoided - in patients with severe liver impairment [<a href="#REF8" class="usa-link" aria-describedby="REF8">8</a>]. There are no data on suzetrigine use during pregnancy, and teratogenic risk cannot be excluded; therefore, the drug is contraindicated in pregnant women until further safety data are available.</p>
<p>Drug-drug interactions</p>
<p>Suzetrigine is both a substrate and an inducer of CYP3A4, which can lead to significant drug interactions [<a href="#REF33" class="usa-link" aria-describedby="REF33">33</a>,<a href="#REF34" class="usa-link" aria-describedby="REF34">34</a>]. Concomitant use with strong CYP3A4 inhibitors, such as ketoconazole, is contraindicated, while dose adjustment is recommended for moderate CYP3A4 inhibitors. Products containing grapefruit should also be avoided due to CYP3A4 inhibition [<a href="#REF33" class="usa-link" aria-describedby="REF33">33</a>,<a href="#REF34" class="usa-link" aria-describedby="REF34">34</a>]. Suzetrigine may reduce the efficacy of sensitive CYP3A4 substrates, including midazolam, and requires careful management of hormonal contraceptives other than levonorgestrel and norethindrone, with a backup nonhormonal method recommended during treatment and for 28 days after discontinuation [<a href="#REF33" class="usa-link" aria-describedby="REF33">33</a>,<a href="#REF34" class="usa-link" aria-describedby="REF34">34</a>]. The impact of suzetrigine on CYP3A4 substrates used in OUD therapy, such as buprenorphine and methadone, remains to be fully established [<a href="#REF34" class="usa-link" aria-describedby="REF34">34</a>]. More pharmacokinetic studies are currently underway to evaluate potential interactions between suzetrigine and other therapeutic agents, including the effects of concomitant use of CYP450 enzyme inhibitors or inducers on the metabolism and bioavailability of the drug [<a href="#REF6" class="usa-link" aria-describedby="REF6">6</a>].</p>
<p>Cost-effectivness</p>
<p>A two-part economic model assessed the cost-effectiveness of suzetrigine versus HB/APAP for treating moderate to severe acute pain, including a short-term decision tree (for the initial seven-day treatment) and a long-term Markov model capturing lifetime outcomes related to OUD [<a href="#REF24" class="usa-link" aria-describedby="REF24">24</a>]. Four health states were modeled: no OUD, OUD, abstinence, and death, with OUD associated with significantly worse quality of life, survival, and healthcare costs. The analysis assumed that suzetrigine carries zero risk of inducing OUD, while 0.43% of patients treated with HB/APAP would develop OUD within three years [<a href="#REF24" class="usa-link" aria-describedby="REF24">24</a>]. Based on wholesale pricing, total discounted lifetime costs for suzetrigine were about $400 lower than for HB/APAP, while yielding slightly higher quality-adjusted life years (QALYs) and life expectancy [<a href="#REF24" class="usa-link" aria-describedby="REF24">24</a>]. Suzetrigine also led to 429 fewer OUD cases per 100,000 patients [<a href="#REF24" class="usa-link" aria-describedby="REF24">24</a>]. Suzetrigine offers faster pain relief in certain procedures, fewer adverse events, and a lower projected risk of OUD than HB/APAP, potentially improving both patient adherence and quality of life [<a href="#REF24" class="usa-link" aria-describedby="REF24">24</a>]. These findings indicate that suzetrigine is a dominant strategy - both less expensive and more effective - compared to opioid-based therapy. The cost-effectiveness was especially sensitive to OUD-related risks and costs associated with HB/APAP [<a href="#REF24" class="usa-link" aria-describedby="REF24">24</a>]. The article’s key limitations relate to uncertainty in the cost-effectiveness modeling, particularly regarding the risk of OUD following short-term use of HB/APAP compared with suzetrigine [<a href="#REF24" class="usa-link" aria-describedby="REF24">24</a>]. The actual incidence of OUD after acute pain treatment is unclear, and the model relies on assumptions that may underestimate or overestimate this risk [<a href="#REF35" class="usa-link" aria-describedby="REF35">35</a>]. Additionally, there are limited data on suzetrigine’s potential to cause OUD, making its long-term safety uncertain. </p>
<p>Future research should focus on better understanding the risk of OUD associated with both acute and chronic pain treatments, distinguishing between opioid and non-opioid therapies [<a href="#REF35" class="usa-link" aria-describedby="REF35">35</a>]. Specifically, studies are needed to clarify suzetrigine’s potential risk for OUD, and to provide more precise estimates of OUD incidence following short-term HB/APAP use. Such research would help refine cost-effectiveness models and ensure that assumptions about OUD risks accurately reflect real-world outcomes.</p>
<p>Advantages of suzetrigine over existing pain medications</p>
<p>Suzetrigine offers an alternative to traditional opioids for managing moderate-to-severe acute pain by providing rapid, clinically meaningful analgesia while avoiding the sedation, euphoria, and addictive potential associated with opioid therapy [<a href="#REF22" class="usa-link" aria-describedby="REF22">22</a>,<a href="#REF31" class="usa-link" aria-describedby="REF31">31</a>]. Clinical trials in postoperative settings such as abdominoplasty and bunionectomy have demonstrated significant reductions in pain intensity (SPID48 up to 48.4%, p &lt; 0.001), with a median onset of relief in just two hours, comparable to hydrocodone/acetaminophen but with better tolerability and fewer adverse events [<a href="#REF22" class="usa-link" aria-describedby="REF22">22</a>,<a href="#REF36" class="usa-link" aria-describedby="REF36">36</a>]. Unlike NSAIDs or opioids, suzetrigine’s targeted peripheral action selectively inhibits NaV1.8 channels in dorsal root ganglia neurons, preventing pain signal transmission without central nervous system side effects, making it particularly suitable for patients at high risk of opioid dependence or adverse drug reactions [<a href="#REF31" class="usa-link" aria-describedby="REF31">31</a>,<a href="#REF35" class="usa-link" aria-describedby="REF35">35</a>]. Furthermore, its favorable safety profile, absence of abuse potential, and potential role in opioid-sparing regimens position suzetrigine as a significant advancement in acute pain management, addressing the urgent need for effective, non-addictive analgesics in the context of the ongoing opioid crisis [<a href="#REF31" class="usa-link" aria-describedby="REF31">31</a>,<a href="#REF36" class="usa-link" aria-describedby="REF36">36</a>,<a href="#REF37" class="usa-link" aria-describedby="REF37">37</a>].</p></section><section id="sec3"><h2 class="pmc_sec_title">Conclusions</h2>
<p>Suzetrigine is a highly selective oral NaV1.8 sodium channel inhibitor that represents a significant advancement in the management of moderate to severe acute pain. Its peripheral, non-opioid mechanism of action allows for effective analgesia without engaging central opioid receptors, thus eliminating risks such as respiratory depression, sedation, and OUD. Clinical trials have demonstrated its efficacy in both surgical and non-surgical pain, with a favorable safety and tolerability profile. The drug showed comparable effectiveness to NSAIDs and low-dose opioids, and, while slightly less potent than high-dose opioids in some settings, it was associated with fewer gastrointestinal and central nervous system side effects. Adverse events were typically mild to moderate, and the incidence of serious drug-related complications was low. Pharmacokinetic properties, including a long half-life and hepatic metabolism, support convenient dosing but require caution in patients with liver impairment. Cost-effectiveness modeling suggests that suzetrigine not only reduces the burden of opioid-related complications, such as addiction, but may also offer long-term economic advantages. While ongoing studies are needed to further clarify long-term safety, drug interactions, and efficacy in special populations, current evidence supports suzetrigine as a promising, safe, and effective non-opioid alternative in acute pain management - especially valuable in the context of the ongoing opioid crisis.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Disclosures</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Conflicts of interest:</strong> In compliance with the ICMJE uniform disclosure form, all authors declare the following:</p>
<p><strong>Payment/services info:</strong> All authors have declared that no financial support was received from any organization for the submitted work.</p>
<p><strong>Financial relationships:</strong> All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.</p>
<p><strong>Other relationships:</strong> All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</p>
</div></div></section><section id="fn-group2" class="fn-group"><h2 class="pmc_sec_title">Author Contributions</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn2">
<p><strong>Concept and design:</strong>  Maciej Mach, Aleksandra Giba, Danuta Szkutnik-Fiedler, Adrian Bryla, Milosz Miedziaszczyk</p>
<p><strong>Acquisition, analysis, or interpretation of data:</strong>  Maciej Mach, Aleksandra Giba, Danuta Szkutnik-Fiedler, Adrian Bryla, Milosz Miedziaszczyk</p>
<p><strong>Drafting of the manuscript:</strong>  Maciej Mach, Aleksandra Giba, Milosz Miedziaszczyk</p>
<p><strong>Critical review of the manuscript for important intellectual content:</strong>  Danuta Szkutnik-Fiedler, Adrian Bryla, Milosz Miedziaszczyk</p>
<p><strong>Supervision:</strong>  Danuta Szkutnik-Fiedler, Adrian Bryla, Milosz Miedziaszczyk</p>
</div></div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="REF1">
<span class="label">1.</span><cite>The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Raja SN, Carr DB, Cohen M, et al.  Pain. 2020;161:1976–1982. doi: 10.1097/j.pain.0000000000001939.</cite> [<a href="https://doi.org/10.1097/j.pain.0000000000001939" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7680716/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32694387/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pain&amp;title=The%20revised%20International%20Association%20for%20the%20Study%20of%20Pain%20definition%20of%20pain:%20concepts,%20challenges,%20and%20compromises&amp;volume=161&amp;publication_year=2020&amp;pages=1976-1982&amp;pmid=32694387&amp;doi=10.1097/j.pain.0000000000001939&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF2">
<span class="label">2.</span><cite>Cognition and pain: a review. Khera T, Rangasamy V. Front Psychol. 2021;12:673962. doi: 10.3389/fpsyg.2021.673962.</cite> [<a href="https://doi.org/10.3389/fpsyg.2021.673962" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8175647/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34093370/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Psychol&amp;title=Cognition%20and%20pain:%20a%20review&amp;volume=12&amp;publication_year=2021&amp;pages=673962&amp;pmid=34093370&amp;doi=10.3389/fpsyg.2021.673962&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF3">
<span class="label">3.</span><cite>Therapeutic basis of clinical pain modulation. Kirkpatrick DR, McEntire DM, Hambsch ZJ, et al.  Clin Transl Sci. 2015;8:848–856. doi: 10.1111/cts.12282.</cite> [<a href="https://doi.org/10.1111/cts.12282" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4641846/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25962969/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Transl%20Sci&amp;title=Therapeutic%20basis%20of%20clinical%20pain%20modulation&amp;volume=8&amp;publication_year=2015&amp;pages=848-856&amp;pmid=25962969&amp;doi=10.1111/cts.12282&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF4">
<span class="label">4.</span><cite>Biased opioid ligands. Faouzi A, Varga BR, Majumdar S. Molecules. 2020;25:4257. doi: 10.3390/molecules25184257.</cite> [<a href="https://doi.org/10.3390/molecules25184257" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7570672/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32948048/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecules&amp;title=Biased%20opioid%20ligands&amp;volume=25&amp;publication_year=2020&amp;pages=4257&amp;pmid=32948048&amp;doi=10.3390/molecules25184257&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF5">
<span class="label">5.</span><cite>Selective inhibition of Na(V)1.8 with VX-548 for acute pain. Jones J, Correll DJ, Lechner SM, et al.  N Engl J Med. 2023;389:393–405. doi: 10.1056/NEJMoa2209870.</cite> [<a href="https://doi.org/10.1056/NEJMoa2209870" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37530822/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Selective%20inhibition%20of%20Na(V)1.8%20with%20VX-548%20for%20acute%20pain&amp;volume=389&amp;publication_year=2023&amp;pages=393-405&amp;pmid=37530822&amp;doi=10.1056/NEJMoa2209870&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF6">
<span class="label">6.</span><cite>VX-548 in the treatment of acute pain. Hang Kong AY, Tan HS, Habib AS. Pain Manag. 2024;14:477–486. doi: 10.1080/17581869.2024.2421749.</cite> [<a href="https://doi.org/10.1080/17581869.2024.2421749" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11721852/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39552600/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pain%20Manag&amp;title=VX-548%20in%20the%20treatment%20of%20acute%20pain&amp;volume=14&amp;publication_year=2024&amp;pages=477-486&amp;pmid=39552600&amp;doi=10.1080/17581869.2024.2421749&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF7">
<span class="label">7.</span><cite>Voltage-gated sodium channels as therapeutic targets. Clare JJ, Tate SN, Nobbs M, et al.  Drug Discov Today. 2000;5:506–520. doi: 10.1016/s1359-6446(00)01570-1.</cite> [<a href="https://doi.org/10.1016/s1359-6446(00)01570-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11084387/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Discov%20Today&amp;title=Voltage-gated%20sodium%20channels%20as%20therapeutic%20targets&amp;volume=5&amp;publication_year=2000&amp;pages=506-520&amp;pmid=11084387&amp;doi=10.1016/s1359-6446(00)01570-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF8">
<span class="label">8.</span><cite>Pharmacology and mechanism of action of suzetrigine, a potent and selective Na(V)1.8 pain signal inhibitor for the treatment of moderate to severe pain. Osteen JD, Immani S, Tapley TL, et al.  Pain Ther. 2025;14:655–674. doi: 10.1007/s40122-024-00697-0.</cite> [<a href="https://doi.org/10.1007/s40122-024-00697-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11914629/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39775738/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pain%20Ther&amp;title=Pharmacology%20and%20mechanism%20of%20action%20of%20suzetrigine,%20a%20potent%20and%20selective%20Na(V)1.8%20pain%20signal%20inhibitor%20for%20the%20treatment%20of%20moderate%20to%20severe%20pain&amp;volume=14&amp;publication_year=2025&amp;pages=655-674&amp;pmid=39775738&amp;doi=10.1007/s40122-024-00697-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF9">
<span class="label">9.</span><cite>Sodium channels as a new target for pain treatment. Chen R, Liu Y, Qian L, Yi M, Yin H, Wang S, Xiang B. Front Pharmacol. 2025;16:1573254. doi: 10.3389/fphar.2025.1573254.</cite> [<a href="https://doi.org/10.3389/fphar.2025.1573254" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11979154/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40206072/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Pharmacol&amp;title=Sodium%20channels%20as%20a%20new%20target%20for%20pain%20treatment&amp;volume=16&amp;publication_year=2025&amp;pages=1573254&amp;pmid=40206072&amp;doi=10.3389/fphar.2025.1573254&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF10">
<span class="label">10.</span><cite>Sensory neuron sodium channels as pain targets; from cocaine to Journavx (VX-548, suzetrigine) Wood JN, Yan N, Huang J, et al.  J Gen Physiol. 2025;157:0. doi: 10.1085/jgp.202513778.</cite> [<a href="https://doi.org/10.1085/jgp.202513778" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12036950/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40294084/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Gen%20Physiol&amp;title=Sensory%20neuron%20sodium%20channels%20as%20pain%20targets;%20from%20cocaine%20to%20Journavx%20(VX-548,%20suzetrigine)&amp;volume=157&amp;publication_year=2025&amp;pages=0&amp;pmid=40294084&amp;doi=10.1085/jgp.202513778&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF11">
<span class="label">11.</span><cite>State-dependent inhibition of NaV1.8 channels by VX-150 and VX-548. Vaelli P, Fujita A, Jo S, Zhang HB, Osorno T, Ma X, Bean BP. Mol Pharmacol. 2024;106:298–308. doi: 10.1124/molpharm.124.000944.</cite> [<a href="https://doi.org/10.1124/molpharm.124.000944" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11585256/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39322410/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Pharmacol&amp;title=State-dependent%20inhibition%20of%20NaV1.8%20channels%20by%20VX-150%20and%20VX-548&amp;volume=106&amp;publication_year=2024&amp;pages=298-308&amp;pmid=39322410&amp;doi=10.1124/molpharm.124.000944&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF12">
<span class="label">12.</span><cite>Drugs in development to manage acute pain. Oliver B, Devitt C, Park G, Razak A, Liu SM, Bergese SD. Drugs. 2025;85:11–19. doi: 10.1007/s40265-024-02118-0.</cite> [<a href="https://doi.org/10.1007/s40265-024-02118-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39560856/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drugs&amp;title=Drugs%20in%20development%20to%20manage%20acute%20pain&amp;volume=85&amp;publication_year=2025&amp;pages=11-19&amp;pmid=39560856&amp;doi=10.1007/s40265-024-02118-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF13">
<span class="label">13.</span><cite>Gender difference in the pharmacokinetics and metabolism of VX-548 in rats. Yu G, Zhou X. Biopharm Drug Dispos. 2024;45:107–114. doi: 10.1002/bdd.2387.</cite> [<a href="https://doi.org/10.1002/bdd.2387" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38573807/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biopharm%20Drug%20Dispos&amp;title=Gender%20difference%20in%20the%20pharmacokinetics%20and%20metabolism%20of%20VX-548%20in%20rats&amp;volume=45&amp;publication_year=2024&amp;pages=107-114&amp;pmid=38573807&amp;doi=10.1002/bdd.2387&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF14">
<span class="label">14.</span><cite>A simple and sensitive ultra-high performance liquid chromatography tandem mass spectrometry method for the quantitative analysis of VX-548 in monkey plasma: method validation and application to pharmacokinetic study. Zhang H, Chen Y, Huang J, et al.  Biomed Chromatogr. 2024;38:5907. doi: 10.1002/bmc.5907.</cite> [<a href="https://doi.org/10.1002/bmc.5907" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38783548/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomed%20Chromatogr&amp;title=A%20simple%20and%20sensitive%20ultra-high%20performance%20liquid%20chromatography%20tandem%20mass%20spectrometry%20method%20for%20the%20quantitative%20analysis%20of%20VX-548%20in%20monkey%20plasma:%20method%20validation%20and%20application%20to%20pharmacokinetic%20study&amp;volume=38&amp;publication_year=2024&amp;pages=5907&amp;pmid=38783548&amp;doi=10.1002/bmc.5907&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF15">
<span class="label">15.</span><cite>Human Protein Atlas: SCN10A gene page.  [
Sep;
2024 
]. 2023. <a href="https://www.proteinatlas.org/search/scn10a" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.proteinatlas.org/search/scn10a</a> <a href="https://www.proteinatlas.org/search/scn10a" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.proteinatlas.org/search/scn10a</a></cite>
</li>
<li id="REF16">
<span class="label">16.</span><cite>Emerging medications and strategies in acute pain management: evolving role of novel sodium and calcium channel blockers, peptide-based pharmacologic drugs, and non-medicinal methods. Kaye AD, Greene DR, Nguyen C, et al.  Curr Pain Headache Rep. 2024;28:853–862. doi: 10.1007/s11916-024-01265-z.</cite> [<a href="https://doi.org/10.1007/s11916-024-01265-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38761297/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Pain%20Headache%20Rep&amp;title=Emerging%20medications%20and%20strategies%20in%20acute%20pain%20management:%20evolving%20role%20of%20novel%20sodium%20and%20calcium%20channel%20blockers,%20peptide-based%20pharmacologic%20drugs,%20and%20non-medicinal%20methods&amp;volume=28&amp;publication_year=2024&amp;pages=853-862&amp;pmid=38761297&amp;doi=10.1007/s11916-024-01265-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF17">
<span class="label">17.</span><cite>Acute pain management pearls: a focused review for the hospital clinician. Hyland SJ, Wetshtein AM, Grable SJ, Jackson MP. Healthcare (Basel) 2022;11:34. doi: 10.3390/healthcare11010034.</cite> [<a href="https://doi.org/10.3390/healthcare11010034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9818465/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36611494/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Healthcare%20(Basel)&amp;title=Acute%20pain%20management%20pearls:%20a%20focused%20review%20for%20the%20hospital%20clinician&amp;volume=11&amp;publication_year=2022&amp;pages=34&amp;pmid=36611494&amp;doi=10.3390/healthcare11010034&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF18">
<span class="label">18.</span><cite>Poorly controlled postoperative pain: prevalence, consequences, and prevention. Gan TJ. J Pain Res. 2017;10:2287–2298. doi: 10.2147/JPR.S144066.</cite> [<a href="https://doi.org/10.2147/JPR.S144066" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5626380/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29026331/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Pain%20Res&amp;title=Poorly%20controlled%20postoperative%20pain:%20prevalence,%20consequences,%20and%20prevention&amp;volume=10&amp;publication_year=2017&amp;pages=2287-2298&amp;pmid=29026331&amp;doi=10.2147/JPR.S144066&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF19">
<span class="label">19.</span><cite>Predicting the transition to chronic pain 6 months after an emergency department visit for acute pain: a prospective cohort study. Friedman BW, Abril L, Naeem F, et al.  J Emerg Med. 2020;59:805–811. doi: 10.1016/j.jemermed.2020.07.016.</cite> [<a href="https://doi.org/10.1016/j.jemermed.2020.07.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7736251/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32919839/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Emerg%20Med&amp;title=Predicting%20the%20transition%20to%20chronic%20pain%206%20months%20after%20an%20emergency%20department%20visit%20for%20acute%20pain:%20a%20prospective%20cohort%20study&amp;volume=59&amp;publication_year=2020&amp;pages=805-811&amp;pmid=32919839&amp;doi=10.1016/j.jemermed.2020.07.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF20">
<span class="label">20.</span><cite>Neuropathic pain and chronic pain as an underestimated interdisciplinary problem. Szewczyk AK, Jamroz-Wiśniewska A, Haratym N, Rejdak K. Int J Occup Med Environ Health. 2022;35:249–264. doi: 10.13075/ijomeh.1896.01676.</cite> [<a href="https://doi.org/10.13075/ijomeh.1896.01676" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10464730/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35040826/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Occup%20Med%20Environ%20Health&amp;title=Neuropathic%20pain%20and%20chronic%20pain%20as%20an%20underestimated%20interdisciplinary%20problem&amp;volume=35&amp;publication_year=2022&amp;pages=249-264&amp;pmid=35040826&amp;doi=10.13075/ijomeh.1896.01676&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF21">
<span class="label">21.</span><cite>Adverse events associated with postoperative opioid analgesia: a systematic review. Wheeler M, Oderda GM, Ashburn MA, Lipman AG. J Pain. 2002;3:159–180. doi: 10.1054/jpai.2002.123652.</cite> [<a href="https://doi.org/10.1054/jpai.2002.123652" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14622770/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Pain&amp;title=Adverse%20events%20associated%20with%20postoperative%20opioid%20analgesia:%20a%20systematic%20review&amp;volume=3&amp;publication_year=2002&amp;pages=159-180&amp;pmid=14622770&amp;doi=10.1054/jpai.2002.123652&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF22">
<span class="label">22.</span><cite>Suzetrigine: the first Nav1.8 inhibitor approved for the treatment of moderate to severe acute pain. Hu S, Lyu D, Gao J. Drug Discov Ther. 2025;19:80–82. doi: 10.5582/ddt.2025.01010.</cite> [<a href="https://doi.org/10.5582/ddt.2025.01010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40010720/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Discov%20Ther&amp;title=Suzetrigine:%20the%20first%20Nav1.8%20inhibitor%20approved%20for%20the%20treatment%20of%20moderate%20to%20severe%20acute%20pain&amp;volume=19&amp;publication_year=2025&amp;pages=80-82&amp;pmid=40010720&amp;doi=10.5582/ddt.2025.01010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF23">
<span class="label">23.</span><cite>Reducing opioid use disorder and overdose deaths in the United States: a dynamic modeling analysis. Stringfellow EJ, Lim TY, Humphreys K, et al.  Sci Adv. 2022;8:0. doi: 10.1126/sciadv.abm8147.</cite> [<a href="https://doi.org/10.1126/sciadv.abm8147" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9232111/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35749492/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Adv&amp;title=Reducing%20opioid%20use%20disorder%20and%20overdose%20deaths%20in%20the%20United%20States:%20a%20dynamic%20modeling%20analysis&amp;volume=8&amp;publication_year=2022&amp;pages=0&amp;pmid=35749492&amp;doi=10.1126/sciadv.abm8147&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF24">
<span class="label">24.</span><cite>The effectiveness and value of suzetrigine for moderate to severe acute pain: a summary from the Institute for Clinical and Economic Review's Midwest Comparative Effectiveness Public Advisory Council. Nikitin D, Rind DM, McQueen B, et al.  J Manag Care Spec Pharm. 2025;31:729–734. doi: 10.18553/jmcp.2025.31.7.729.</cite> [<a href="https://doi.org/10.18553/jmcp.2025.31.7.729" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12204333/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40577034/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Manag%20Care%20Spec%20Pharm&amp;title=The%20effectiveness%20and%20value%20of%20suzetrigine%20for%20moderate%20to%20severe%20acute%20pain:%20a%20summary%20from%20the%20Institute%20for%20Clinical%20and%20Economic%20Review's%20Midwest%20Comparative%20Effectiveness%20Public%20Advisory%20Council&amp;volume=31&amp;publication_year=2025&amp;pages=729-734&amp;pmid=40577034&amp;doi=10.18553/jmcp.2025.31.7.729&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF25">
<span class="label">25.</span><cite>Insights into the voltage-gated sodium channel, Na(V)1.8, and its role in visceral pain perception. Heinle JW, Dalessio S, Janicki P, Ouyang A, Vrana KE, Ruiz-Velasco V, Coates MD. Front Pharmacol. 2024;15:1398409. doi: 10.3389/fphar.2024.1398409.</cite> [<a href="https://doi.org/10.3389/fphar.2024.1398409" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11158627/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38855747/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Pharmacol&amp;title=Insights%20into%20the%20voltage-gated%20sodium%20channel,%20Na(V)1.8,%20and%20its%20role%20in%20visceral%20pain%20perception&amp;volume=15&amp;publication_year=2024&amp;pages=1398409&amp;pmid=38855747&amp;doi=10.3389/fphar.2024.1398409&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF26">
<span class="label">26.</span><cite>The role of voltage-gated sodium channels in pain signaling. Bennett DL, Clark AJ, Huang J, Waxman SG, Dib-Hajj SD. Physiol Rev. 2019;99:1079–1151. doi: 10.1152/physrev.00052.2017.</cite> [<a href="https://doi.org/10.1152/physrev.00052.2017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30672368/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Physiol%20Rev&amp;title=The%20role%20of%20voltage-gated%20sodium%20channels%20in%20pain%20signaling&amp;volume=99&amp;publication_year=2019&amp;pages=1079-1151&amp;pmid=30672368&amp;doi=10.1152/physrev.00052.2017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF27">
<span class="label">27.</span><cite>Targeting Nav1.8 with the nonopioid antagonist suzetrigine in analgesia: cause for optimism? Attal N, Barrot M. Br J Anaesth. 2025;11:7–912. doi: 10.1016/j.bja.2025.07.043.</cite> [<a href="https://doi.org/10.1016/j.bja.2025.07.043" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40796490/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Anaesth&amp;title=Targeting%20Nav1.8%20with%20the%20nonopioid%20antagonist%20suzetrigine%20in%20analgesia:%20cause%20for%20optimism?&amp;volume=11&amp;publication_year=2025&amp;pages=7-912&amp;pmid=40796490&amp;doi=10.1016/j.bja.2025.07.043&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF28">
<span class="label">28.</span><cite>Small molecule-mediated targeted protein degradation of voltage-gated sodium channels involved in pain (Preprint) Chamessian A, Payne M, Gordon I, Zhou M, Gereau R. bioRxiv. 2025;2025:4079.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=bioRxiv&amp;title=Small%20molecule-mediated%20targeted%20protein%20degradation%20of%20voltage-gated%20sodium%20channels%20involved%20in%20pain%20(Preprint)&amp;volume=2025&amp;publication_year=2025&amp;pages=4079&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF29">
<span class="label">29.</span><cite>Suzetrigine (VX-548): bidding goodbye to opioids: the latest oral non-opioid analgesic for acute pain. Chittoria K, Sharma A, Kothari N, Kumari K. Saudi J Anaesth. 2025;19:384–386. doi: 10.4103/sja.sja_366_25.</cite> [<a href="https://doi.org/10.4103/sja.sja_366_25" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12240521/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40642648/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Saudi%20J%20Anaesth&amp;title=Suzetrigine%20(VX-548):%20bidding%20goodbye%20to%20opioids:%20the%20latest%20oral%20non-opioid%20analgesic%20for%20acute%20pain&amp;volume=19&amp;publication_year=2025&amp;pages=384-386&amp;pmid=40642648&amp;doi=10.4103/sja.sja_366_25&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF30">
<span class="label">30.</span><cite>Suzetrigine, a nonopioid NaV 1.8 inhibitor for treatment of moderate-to-severe acute pain: two phase 3 randomized clinical trials. Bertoch T, D'Aunno D, McCoun J, et al.  Anesthesiology. 2025;142:1085–1099. doi: 10.1097/ALN.0000000000005460.</cite> [<a href="https://doi.org/10.1097/ALN.0000000000005460" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12061372/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40117446/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Anesthesiology&amp;title=Suzetrigine,%20a%20nonopioid%20NaV%201.8%20inhibitor%20for%20treatment%20of%20moderate-to-severe%20acute%20pain:%20two%20phase%203%20randomized%20clinical%20trials&amp;volume=142&amp;publication_year=2025&amp;pages=1085-1099&amp;pmid=40117446&amp;doi=10.1097/ALN.0000000000005460&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF31">
<span class="label">31.</span><cite>Suzetrigine, a non-opioid Na(V)1.8 inhibitor with broad applicability for moderate-to-severe acute pain: a phase 3 single-arm study for surgical or non-surgical acute pain. McCoun J, Winkle P, Solanki D, et al.  J Pain Res. 2025;18:1569–1576. doi: 10.2147/JPR.S509144.</cite> [<a href="https://doi.org/10.2147/JPR.S509144" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11955400/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40165940/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Pain%20Res&amp;title=Suzetrigine,%20a%20non-opioid%20Na(V)1.8%20inhibitor%20with%20broad%20applicability%20for%20moderate-to-severe%20acute%20pain:%20a%20phase%203%20single-arm%20study%20for%20surgical%20or%20non-surgical%20acute%20pain&amp;volume=18&amp;publication_year=2025&amp;pages=1569-1576&amp;pmid=40165940&amp;doi=10.2147/JPR.S509144&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF32">
<span class="label">32.</span><cite>Vertex's non-opioid painkiller passes phase III tests. Mullard A. Nat Rev Drug Discov. 2024;23:162. doi: 10.1038/d41573-024-00029-z.</cite> [<a href="https://doi.org/10.1038/d41573-024-00029-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38347158/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Drug%20Discov&amp;title=Vertex's%20non-opioid%20painkiller%20passes%20phase%20III%20tests&amp;volume=23&amp;publication_year=2024&amp;pages=162&amp;pmid=38347158&amp;doi=10.1038/d41573-024-00029-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF33">
<span class="label">33.</span><cite>Suzetrigine (Journavx) - a sodium channel blocker for acute pain. The Medical Letter. Med Lett Drugs Ther. 2025;67:33–35. doi: 10.58347/tml.2025.1723a.</cite> [<a href="https://doi.org/10.58347/tml.2025.1723a" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40009986/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Med%20Lett%20Drugs%20Ther&amp;title=Suzetrigine%20(Journavx)%20-%20a%20sodium%20channel%20blocker%20for%20acute%20pain&amp;volume=67&amp;publication_year=2025&amp;pages=33-35&amp;pmid=40009986&amp;doi=10.58347/tml.2025.1723a&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF34">
<span class="label">34.</span><cite>FDA approved drug products: JOURNAVX (suzetrigine) tablets, for oral use.  [
Jul;
2025 
]. 2025. <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/219209s000lbl.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/219209s000lbl.pdf</a> <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/219209s000lbl.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/219209s000lbl.pdf</a></cite>
</li>
<li id="REF35">
<span class="label">35.</span><cite>Neuroimaging of opioid effects in humans across conditions of acute administration, chronic pain therapy, and opioid use disorder. Martucci KT. Trends Neurosci. 2024;47:418–431. doi: 10.1016/j.tins.2024.04.005.</cite> [<a href="https://doi.org/10.1016/j.tins.2024.04.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11168870/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38762362/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20Neurosci&amp;title=Neuroimaging%20of%20opioid%20effects%20in%20humans%20across%20conditions%20of%20acute%20administration,%20chronic%20pain%20therapy,%20and%20opioid%20use%20disorder&amp;volume=47&amp;publication_year=2024&amp;pages=418-431&amp;pmid=38762362&amp;doi=10.1016/j.tins.2024.04.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF36">
<span class="label">36.</span><cite>Suzetrigine: a novel non-opioid analgesic for acute pain management - a review. Jones M, Demery A, Al-Horani RA. Drugs Drug Candidates. 2025;4:30032. doi: 10.3390/ddc4030032.</cite> [<a href="https://doi.org/10.3390/ddc4030032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12337992/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40799996/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drugs%20Drug%20Candidates&amp;title=Suzetrigine:%20a%20novel%20non-opioid%20analgesic%20for%20acute%20pain%20management%20-%20a%20review&amp;volume=4&amp;publication_year=2025&amp;pages=30032&amp;pmid=40799996&amp;doi=10.3390/ddc4030032&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="REF37">
<span class="label">37.</span><cite>Suzetrigine approval breaks a 25-year silence: a new era in non-opioid acute pain management. Sibomana O, Okereke M, Hakayuwa CM. J Pain Res. 2025;18:2805–2808. doi: 10.2147/JPR.S526851.</cite> [<a href="https://doi.org/10.2147/JPR.S526851" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12152734/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40502436/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Pain%20Res&amp;title=Suzetrigine%20approval%20breaks%20a%2025-year%20silence:%20a%20new%20era%20in%20non-opioid%20acute%20pain%20management&amp;volume=18&amp;publication_year=2025&amp;pages=2805-2808&amp;pmid=40502436&amp;doi=10.2147/JPR.S526851&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Cureus are provided here courtesy of <strong>Cureus Inc.</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.7759/cureus.90755"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/cureus-0017-00000090755.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (681.6 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12372998/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12372998/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372998%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372998/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12372998/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12372998/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12372998/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12372998/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12372998/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="njQbfHjB12ujkcYKbQDIIanjaKSwteVLjW4OG52j7fgJkATFXP02eJOvEzfcLEGh">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
